Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Acquisition

11 Dec 2006 07:01

CareCapital Group plc11 December 2006 For release at 0700h, 11 December 2006 CareCapital Group Plc ("CareCapital" or "the Company") Investment and Development Programme in Germany CareCapital Group Plc, the healthcare real estate company which listed on AIM inAugust (CARE), announces that it has completed the acquisition of a majormedical centre in Berlin as the first part of an initial €35 million investmentand development programme in Germany. This first investment, at an acquisition cost of • 9.2 million, is a 4,100 sq mmedical facility housing 34 tenants including physicians, dentists, a dentallab, diagnostic facilities, a pharmacy and other healthcare related retailers.An additional €4.2 million acquisition of a 2,800 sq m medical centre housing 25medical tenants situated to the South East of Berlin together with its adjoiningdevelopment site is scheduled for completion in February 2007. These two investments represent the initial stage of the €35 million programme,on which heads of terms have been agreed with a German developer/constructioncompany, with funding supplied by a major German bank. The programme currentlyincludes two further development sites in the Berlin area. Any additionalfunding for the programme will come from the Company's existing resources andfacilities. The programme enables CareCapital to capitalise on recent changes in Germanlegislation which favour primary care provision from large, integrated medicalcare centres. Michael Sinclair, Chairman, commented: "The investment and development programmein Germany follows extensive research, conducted by CareCapital over the pastmonths and represents an exciting opportunity for the Company. It will notimpact on our development programme in the UK which remains on target. "CareCapital will leverage its UK experience to manage and develop the mixedeconomy healthcare facilities in Germany that will increasingly become a featureof UK primary care provision as services are moved out of the hospitalenvironment to community locations in accordance with Government policy. Inaddition, the programme will bring us high quality assets at yieldssignificantly greater than those currently prevailing in the UK and withsimilarly comparable covenant profiles." For further information please visit www.carecapital.co.uk or contact: CareCapital Group Plc Daniel Stewart & Co. Plc Tavistock CommunicationsPaul Stacey, Managing Director Lindsay Mair, Director - Simon Hudson,Shareen Courtney, Marketing Corporate Finance Richard SunderlandTel: 020 7034 1949 Tel: 020 7776 6550 Tel: 020 7920 3150pstacey@carecapital.co.uk lindsay.mair@danielstewart.co.uk shudson@tavistock.co.ukscourtney@carecapital.co.uk rsunderland@tavistock.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Mar 202312:36 pmRNSUpdate on Secured Convertible Note Facility
1st Mar 20232:54 pmRNSSecured Convertible Note Facility & other matters
1st Mar 20232:05 pmRNSSecond Price Monitoring Extn
1st Mar 20232:00 pmRNSPrice Monitoring Extension
27th Jan 20234:53 pmEQSHardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date
18th Jan 20232:00 pmRNSOperational update
17th Jan 20233:10 pmEQSHardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV
30th Dec 20221:00 pmRNSTotal Voting Rights
30th Dec 20229:24 amRNSDirector/PDMR Shareholding
29th Dec 20223:12 pmRNSDirector/PDMR Shareholding
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 202212:40 pmRNSSecond Price Monitoring Extn
23rd Dec 202212:35 pmRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSEquity Subscription and Issue of Warrants
1st Dec 20227:00 amRNSIssue of Equity
28th Nov 20227:00 amRNSStudy showcases the potential superiority of LIGHT
3rd Nov 20223:20 pmRNSInvestor / Analyst Event Update
31st Oct 20225:00 pmRNSTotal Voting Rights
27th Oct 20227:31 amRNSPresentation highlights superiority of LIGHT
21st Oct 20227:00 amRNSNotice of Investor / Analyst Event
18th Oct 20227:00 amRNSEquity Subscription and Issue of Warrants
30th Sep 20225:00 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSInterim Results
29th Sep 20227:15 amEQSHardman & Co Research on Advanced Oncotherapy: Major milestone achieved
27th Sep 202210:30 amRNSLIGHT accelerator fully operational
31st Aug 20225:00 pmRNSTotal Voting Rights
23rd Aug 20223:09 pmRNSUpdate re admission of Subscription Shares
19th Aug 20227:00 amRNSEquity Subscription and Issue of Warrants
17th Aug 20225:30 pmRNSHolding(s) in Company
3rd Aug 20227:00 amRNSEquity Subscription and Issue of Warrants
29th Jul 20224:30 pmRNSResult of AGM
7th Jul 202212:30 pmRNSHolding(s) in Company
30th Jun 20225:00 pmRNSTotal Voting Rights
30th Jun 20229:00 amRNSFinal results for the year ended 31 December 2021
28th Jun 20227:00 amRNSEquity Subscription and Issue of Warrants
13th Jun 20227:00 amRNSEquity Subscription and Issue of Warrants
31st May 20225:00 pmRNSTotal Voting Rights
27th May 202212:17 pmRNSHolding(s) in Company
11th May 20227:00 amRNSLIGHT system potential in delivering FLASH
29th Apr 20225:00 pmRNSTotal Voting Rights
27th Apr 20227:00 amRNSVideo showcases progress on LIGHT system process
26th Apr 20227:00 amRNSOperational update
22nd Apr 20227:00 amRNSUpdate re admission of Subscription Shares
19th Apr 20224:05 pmRNSUpdate re admission of Subscription Shares
12th Apr 20227:13 amRNSEquity Subscription and Issue of Warrants
31st Mar 20225:00 pmRNSTotal Voting Rights
25th Mar 20229:30 amRNS£2m Subscription, Add'l Loan and Issue of Warrants
14th Mar 20227:15 amEQSHardman & Co Research: Advanced Oncotherapy (AVO) - LIGHT: regulatory update
4th Mar 20229:00 amRNSDirector/PDMR Notification
3rd Mar 20226:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.